Calls
2
u/Buddah_Chillz420
Reddit r/wallstreetbets
Win Rate
100.0%
return
+77.6%
Loading charts...
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Apr 19
$4.01
+78.6%
The author claims "Psychedelics getting Trump sign off," implying favorable regulatory changes. If regulatory approval accelerates, companies like ATAI (Atai Life Sciences) working on psychedelic therapies could see increased investor interest and valuation. The author is holding and believes the uptrend will continue, making it a long opportunity based on policy sentiment. The post provides zero evidence; political news may be misinterpreted or irrelevant. Regulatory paths are long and uncertain. Stock is highly volatile and speculative.
The author claims "Psychedelics getting Trump sign off," implying favorable regulatory changes. If regulatory approval accelerates, companies like ATAI (Atai Life Sciences) working on psychedelic therapies could see increased investor interest and valuation. The author is holding and believes the uptrend will continue, making it a long opportunity based on policy sentiment. The post provides zero evidence; political news may be misinterpreted or irrelevant. Regulatory paths are long and uncertain. Stock is highly volatile and speculative.
Pharma & Biotech
Long
Apr 19
$6.66
+76.6%
Compass Pathways (CMPS) is listed as one of the author's holdings poised to benefit from accelerated psychedelic therapy approvals. The author's logic is that sector-wide positive news will lift all boats in the psychedelic biotech space. A generic long bet on the sector, tied to a vague political headline. CMPS has its own clinical trial risks. The post's catalyst is not specific to CMPS. Stock performance may not correlate with political news.
Compass Pathways (CMPS) is listed as one of the author's holdings poised to benefit from accelerated psychedelic therapy approvals. The author's logic is that sector-wide positive news will lift all boats in the psychedelic biotech space. A generic long bet on the sector, tied to a vague political headline. CMPS has its own clinical trial risks. The post's catalyst is not specific to CMPS. Stock performance may not correlate with political news.
Pharma & Biotech
Showing 2 of 2 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/Buddah_Chillz420 has 2 trade ideas tracked on Buzzberg across 2 tickers since April 2026. Most covered: ATAI, CMPS, DFTX.
